Topic Hubs
AI drug discovery: News, analysis and interviews
Antibody-drug conjugates: The next wave of targeted cancer drugs
Biopharma M&A and dealmaking: Who’s buying and why
Biopharma people moves: CEO changes, executive hires, board positions
Biotech IPOs: Tracking the market for new public offerings
Biotech venture funding: Who’s raising and where the money is going
Cell and gene therapy manufacturing: Scaling the next frontier
China biotech: Licensing deals and the Biosecure Act
CRISPR and gene editing: The push for in vivo therapies
Drug pricing and the IRA: Tracking the government's negotiation power
FDA policy and drug approvals: What’s changing for biopharma
GLP-1 drugs: The obesity pipeline race and what's next
Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Signal
More
Work at Endpoints
Biopharma Jobs
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Valneva to cut up to 15% of jobs as reduced travel hits vaccine demand
3 days ago
Pharma
Post-Hoc: What brought down the FDA commissioner
3 days ago
FDA+
Behind Galapagos’ transformation into Lakefront Biotherapeutics
3 days ago
R&D
Pharma
FDA Commissioner Makary resigns
4 days ago
FDA+
Trump plans to fire Makary from FDA role, according to reports
Last week
FDA+
‘Pharma, not really’: Why AI’s top young talent isn’t interested in a career at big drugmakers
Last week
AI
Pharma
BioNTech to scale down manufacturing, over 1,800 jobs on the line
Last week
Pharma
Manufacturing
Q&A: Seaport CEO and CSO on learning from Karuna and the future of CNS research
3 weeks ago
Financing
R&D
Acelyrin founder Shao-Lee Lin emerges at Cue, as it becomes latest to license from China
3 weeks ago
Deals
China
GSK CEO says team reorg could be in the cards pending upcoming Phase 3 readouts
3 weeks ago
Pharma
Q&A: Intellia CEO talks first Phase 3 CRISPR readout and what’s next
3 weeks ago
R&D
Substance use disorder biotech Tempero to close after earlier 'serious' safety event
4 weeks ago
Startups
R&D
David Reese to retire from Amgen
4 weeks ago
BridgeBio’s oncology spinoff swaps out CEOs as it seeks to accelerate KRAS work
4 weeks ago
Sanofi’s new CEO faces a reckoning on immunology-focused R&D strategy
4 weeks ago
R&D
Pharma
Merck's Welireg combo fails in first-line kidney cancer
4 weeks ago
R&D
Replimune looks ahead as repeat CRL speeds the company's decline
Last month
Pharma
FDA+
Exclusive: Click Therapeutics cuts 27% of workforce after $50M raise
Last month
Health Tech
Exclusive: FDA narrows in on search for new biologics and vaccines leader
Last month
FDA+
Exclusive: China's Ailux adds AstraZeneca vet as CSO in hiring spree while eyeing clinic in 2027
Last month
China
AI
PhRMA head Steve Ubl to step down at end of year
Last month
Pharma
Novo cuts 400 jobs in Indiana as Scholar Rock refiles drug linked to the factory
Last month
Pharma
Manufacturing
IO Biotech will file for bankruptcy after failure of cancer vaccine in key trial
Last month
Exclusive: ViiV R&D head Kimberly Smith heads to retirement after three decades in HIV care
Last month
R&D
1
2
3
4
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
State
{@!--CONSENT--!@}
Submit
